High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study
Authors:
Open Access
- 31 January 2023
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7 (2) , 100061
Abstract
No abstract availableKeywords
Funding Information
- Swedish Orphan Biovitrum
This publication has 30 references indexed in Scilit:
- Associations of quality of life, pain, and self-reported arthritis with age, employment, bleed rate, and utilization of hemophilia treatment center and health care provider services: results in adults with hemophilia in the HERO studyPatient Preference and Adherence, 2015
- Assessment and management of pain in children and adolescents with bleeding disorders: a cross‐sectional study from three haemophilia centresHaemophilia, 2015
- Managing chronic pain in adults with haemophilia: current status and call to actionHaemophilia, 2014
- Forgetting to remember or remembering to forget: A study of the recall period length in health care survey questionsJournal of Health Economics, 2014
- Antipsychotics for acute and chronic pain in adultsCochrane Database of Systematic Reviews, 2013
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- Prevalence of depression in adults with haemophiliaHaemophilia, 2012
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Antidepressant drugs as adjuvant analgesicsJournal of Pain and Symptom Management, 1994
- Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and BJournal of Internal Medicine, 1992